NYSE · CAH
Healthcare · Medical - Distribution
$237.57
Down-$1.39 (-0.58%)
Updated Oct 10, 2026, 7:27 PM
SID Score
6.6/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CAH
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
CAH closed at $237.57 after 21 trading sessions, up 1.28% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $237.79 | $239.81 | $236.37 | $237.57 | 1.03M |
| Oct 8, 2026 | $231.50 | $241.96 | $231.25 | $238.96 | 1.54M |
| Oct 7, 2026 | $233.61 | $235.97 | $230.61 | $232.16 | 1.1M |
| Oct 6, 2026 | $233.69 | $235.19 | $231.635 | $233.44 | 1.15M |
| Oct 5, 2026 | $229.11 | $234.18 | $228.59 | $233.12 | 1.72M |
| Oct 2, 2026 | $229.54 | $231.10 | $224.45 | $228.30 | 1.86M |
| Oct 1, 2026 | $227.55 | $235.95 | $227.3993 | $230.09 | 1.91M |
| Sep 30, 2026 | $223.66 | $226.485 | $222.07 | $222.50 | 1.94M |
| Sep 29, 2026 | $218.54 | $224.01 | $216.70 | $223.91 | 973.62K |
| Sep 28, 2026 | $219.37 | $221.97 | $218.90 | $220.29 | 2.39M |
| Sep 25, 2026 | $222.00 | $223.02 | $219.10 | $220.22 | 2.09M |
| Sep 24, 2026 | $222.08 | $225.37 | $221.95 | $222.62 | 3.48M |
| Sep 23, 2026 | $221.79 | $225.64 | $220.94 | $221.27 | 1.22M |
| Sep 22, 2026 | $227.17 | $228.44 | $221.21 | $222.04 | 2.78M |
| Sep 21, 2026 | $225.28 | $227.58 | $223.54 | $225.75 | 1.19M |
| Sep 18, 2026 | $225.29 | $226.1197 | $221.6974 | $225.38 | 4.14M |
| Sep 17, 2026 | $232.71 | $232.71 | $226.02 | $226.34 | 2.26M |
| Sep 16, 2026 | $233.07 | $234.90 | $232.09 | $232.54 | 1.22M |
| Sep 15, 2026 | $233.89 | $234.83 | $230.34 | $232.65 | 1.8M |
| Sep 14, 2026 | $236.76 | $237.565 | $232.60 | $234.89 | 2.17M |
| Sep 11, 2026 | $238.77 | $239.43 | $232.60 | $234.57 | 1.11M |
The latest Smart Investors Daily articles mentioning CAH.
Company
Market Activity
Research & News
CAH research
Company profile and research snapshot.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | RBC Capital | Outperform | — |
| Aug 13, 2026 | JP Morgan | Neutral | — |
| Aug 13, 2026 | TD Cowen | Buy | — |
| Aug 13, 2026 | Barclays | Overweight | — |
| Aug 12, 2026 | Morgan Stanley | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 1, 2026
Investing.com -- Cardinal Health Inc (NYSE:CAH) shares rose 3.7% in Thursday trading after the company announced an extension of its drug distribution agreement with CVS Health through June 2032.
Yahoo · Oct 1, 2026
Cardinal Health (NYSE:CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extended agreement will maintain the existing scope of distribution services provided by Cardinal Health to CVS Health.
Benzinga · Oct 1, 2026
Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.
Yahoo · Oct 1, 2026
Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CAH.
